Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence StudyShort Communication Published on 2021-06-012022-10-27 Journal: Asian Pacific Journal of Cancer Prevention : APJCP [Category] COVID-19, [키워드] age all age group anticancer Asymptomatic asymptomatic patient Cancer cancer patient Cancer patients change cohort study coronavirus disease COVID-19 COVID-19 symptom COVID-19 transmission COVID-19- SARS-CoV-2- cancer- oncology- asymptomatic determine diagnostic disease elevated ELISA enrolled enzyme-linked immunosorbent Epidemic evaluated Evidence General population IgG and IgM Infection investigated morbidity and mortality outbreak pandemic spreads Patient positive risk SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection Seroconversion serologic serological test Serologically Seroprevalence serum sample Sex the SARS-CoV-2 therapy while [DOI] 10.31557/APJCP.2021.22.6.1667 PMC 바로가기 [Article Type] Short Communication
Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence StudyShort Communication Published on 2021-06-012022-10-27 Journal: Asian Pacific Journal of Cancer Prevention : APJCP [Category] Coronavirus, COVID-19, MERS, SARS, [키워드] age all age group anticancer Asymptomatic asymptomatic patient Cancer cancer patient Cancer patients change cohort study coronavirus disease COVID-19 COVID-19 symptom COVID-19 transmission COVID-19- SARS-CoV-2- cancer- oncology- asymptomatic determine diagnostic disease elevated ELISA enrolled enzyme-linked immunosorbent Epidemic evaluated Evidence General population IgG and IgM Infection investigated morbidity and mortality outbreak pandemic spreads Patient positive risk SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection Seroconversion serologic serological test Serologically Seroprevalence serum sample Sex the SARS-CoV-2 therapy while [DOI] 10.31557/APJCP.2021.22.6.1667 PMC 바로가기 [Article Type] Short Communication
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)Review Published on 2021-06-012022-10-27 Journal: BioMed Research International [Category] COVID-19, [키워드] acute respiratory distress addition addressed Angiotensin-converting enzyme Antibody-dependent enhancement bind cause challenge change characterized Clinical management clinical manifestation clinically Complete complications of COVID-19 Coronavirus disease-19 COVID-19 COVID-19 patient COVID-19 patients current Cytokine storm described develop development drug effective eosinophil greater Hypothesis Immunity immunopathological include individual Infection infiltration lack lung lymphopenia management mechanism mechanisms membrane molecular mononuclear cell mutant pathogenesis of SARS-CoV-2 pathophysiology patients Pneumonia Prevent protease PROTECT provide reduce Replication Research respiratory S glycoprotein SARS-CoV-2 serological test Spread status T cell tested the antibody response therapeutic therapeutic intervention Treatment understanding Vaccine variant variants of SARS-CoV-2 variations Viral load virulence virus virus transmission [DOI] 10.1155/2021/8160860 PMC 바로가기 [Article Type] Review
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)Review Published on 2021-06-012022-10-27 Journal: BioMed Research International [Category] Coronavirus, COVID-19, MERS, SARS, [키워드] acute respiratory distress addition addressed Angiotensin-converting enzyme Antibody-dependent enhancement bind cause challenge change characterized Clinical management clinical manifestation clinically Complete complications of COVID-19 Coronavirus disease-19 COVID-19 COVID-19 patient COVID-19 patients current Cytokine storm described develop development drug effective eosinophil greater Hypothesis Immunity immunopathological include individual Infection infiltration lack lung lymphopenia management mechanism mechanisms membrane molecular mononuclear cell mutant pathogenesis of SARS-CoV-2 pathophysiology patients Pneumonia Prevent protease PROTECT provide reduce Replication Research respiratory S glycoprotein SARS-CoV-2 serological test Spread status T cell tested the antibody response therapeutic therapeutic intervention Treatment understanding Vaccine variant variants of SARS-CoV-2 variations Viral load virulence virus virus transmission [DOI] 10.1155/2021/8160860 PMC 바로가기 [Article Type] Review
Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin아프리카 기원의 혈청 샘플에서 상업적으로 이용 가능한 SARS-CoV-2 IgG ELISA의 제한된 특이성Article Published on 2021-06-012022-09-11 Journal: Tropical medicine & international health : TM & IH [Category] MERS, SARS, 진단, 치료법, [키워드] Africa African analysed Antigen binding collected common cold common cold CoV common cold CoVs country COVID-19 COVID-19 pandemic CoVs diagnostics Donor elicited ELISA ELISAs Endemic enzyme enzyme-linked immunosorbent assay Euroimmun Europe Germany house IgG IgG antibodies IgG antibody immune response immune responses Immunoglobulin Immunoglobulin G Infection inhibit Interference Limited mandatory much lower Nigeria novel Novel coronavirus nucleocapsid OC43 parasites pathogen Pathogens Population positive protocol reduced SARS-CoV-2 SARS-CoV-2 IgG sera Seroepidemiologic studies serological test Serological tests serum serum sample serum/plasma significantly South America Specific Specificities specificity virus Virus neutralisation viruses [DOI] 10.1111/tmi.13569 PMC 바로가기 [Article Type] Article
Vertical Flow Cellulose-Based Assays for SARS-CoV-2 Antibody Detection in Human Serum인간 혈청에서 SARS-CoV-2 항체 검출을 위한 수직 유동 셀룰로스 기반 분석Article Published on 2021-05-282022-09-11 Journal: ACS Sensors [Category] MERS, SARS, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 antibody Antibody test Antigen antigen tests approval capture Cellulose cellulose-binding domain chemiluminescence immunoassay clinical sample clinical samples complement Coronavirus-2 COVID-19 COVID-19 pandemic demonstrated detect detection diminished Emergency use extreme Flow flow rates horseradish peroxidase Human intensity Laboratory Lateral flow test Lateral flow tests membrane nucleic acid paper-based assay peroxidase point of care Rapid replacing reporter respiratory SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 antibody test SARS-CoV-2 antigen SARS-CoV-2 antigens sensitivity serological test Serological tests serology seroprevalence survey serum severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 signal intensity supply chains US FDA vertical vertical flow. were used [DOI] 10.1021/acssensors.1c00235 PMC 바로가기 [Article Type] Article
Prospective Observational COVID-19 Screening and Monitoring of Asymptomatic Cancer Center Health-Care Workers with a Rapid Serological TestBrief Report Published on 2021-05-282022-10-31 Journal: Diagnostics [Category] COVID-19, [키워드] Asymptomatic Cancer Cancer center Cancer patients center chemiluminescence immunoassay CLIA Cohort COVID-19 expression HCW Health-care workers help high risk IgG IgG positivity IgM monitoring nine oropharyngeal swab performed positive Prevalence Prospective Rapid RT-PCR SARS-CoV-2 SARS-COV-2 infection Screening serological test subject Test virus worker [DOI] 10.3390/diagnostics11060975 PMC 바로가기 [Article Type] Brief Report
Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adultsSARS-CoV-2 감염 6개월 후 소아의 혈청 IgG 수치 및 성인과의 비교Original Article Published on 2021-05-222022-09-11 Journal: European journal of pediatrics [Category] MERS, SARS, 진단, 치료기술, [키워드] affected age anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgM antibody antibody levels Antibody Response Antibody responses blood test blood tests both group both groups caution children clinical manifestations collected correlation COVID-19 Ct value cycle threshold declined detect Diagnosis enrolled Evidence General population highlight IgG IgG level IgG titer IgG titers Immunity implication Infection lack no significant difference no significant differences occurred outbreak parent parents pediatric performed PROTECT Quantitative real-time RT-PCR recent Reinfection SARS-CoV-2 SARS-COV-2 infection serological test Serological tests Sex significantly Surveillance Swab the antibody response Therapies Vaccinations virus waned [DOI] 10.1007/s00431-021-04124-w PMC 바로가기 [Article Type] Original Article
Flow cytometry detection of sustained humoral immune response (IgG + IgA) against native spike glycoprotein in asymptomatic/mild SARS-CoV-2 infection무증상/경증 SARS-CoV-2 감염에서 천연 스파이크 당단백질에 대한 지속적인 체액성 면역 반응(IgG + IgA)의 유세포 분석 검출Article Published on 2021-05-212022-09-01 Journal: Scientific Reports [Category] SARS, 진단, 치료기술, [키워드] Biological techniques cause caused classic CLIA COVID-19 Cytometry Efficacy ELISA evaluate Flow functional General population humoral immune response IgA antibodies IgG immunological immunology Infection membrane pandemic S-protein SARS-CoV-2 SARS-COV-2 infection serological serological test Serological tests spike glycoprotein sustained the disease transfected cell vaccination virus [DOI] 10.1038/s41598-021-90054-4 PMC 바로가기 [Article Type] Article
Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population브라질 아마존 인구에서 COVID-19 이후 항 SARS-CoV-2 IgG 항체의 역학Observational Study Published on 2021-05-152022-09-01 Journal: BMC Infectious Diseases [Category] SARS, 임상, 진단, 치료기술, [키워드] (coronavirus disease 2019 Amazon anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody antibody blood sample both sexes Characteristics clinical conditions coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 diagnosis detectable diagnosed with COVID-19 Diagnosis disease severity Dynamics epidemiological evaluated first test first visit Frequency Hospital stay IgG IgG antibodies IgG antibody IgG response individual Laboratory Longevity manifestation Older oxygen persistence Prevalence reactivity recruited reported symptom respiratory Result SARS-CoV-2 selected serological profile serological test Serological testing Severe acute respiratory syndrome severity supplemental oxygen Symptom Symptoms Volunteer volunteers [DOI] 10.1186/s12879-021-06156-x PMC 바로가기 [Article Type] Observational Study